Inici › Càncer de bufeta › Califòrnia › Orange
Assaigs clínics de Càncer de bufeta a Orange, CA
12 estudis de Càncer de bufeta busquen participants en centres de Orange i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
ReclutantFase 3
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
ReclutantFase 2
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
ReclutantFase 1/2
- UC Irvine Health, Orange
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
ReclutantFase 3
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
ReclutantFase 2
- University of California, Irvine, Orange
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
ReclutantFase 2
- University of California Irvine Medical Center, Orange
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
ReclutantFase 1
- University of California - Irvine, Orange
Patient-Derived Xenografts to Reduce Cancer Health Disparities
ReclutantEstudi observacional
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
ReclutantFase 3
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
ReclutantFase 2
- UC Irvine Health, Orange
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
ReclutantFase 2
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutantEstudi observacional
- Massive Bio SYNERGY-AI site, Orange
Assaigs de Càncer de bufeta en altres ciutats
- New York City, NY35 estudis
- Nashville, TN31 estudis
- Houston, TX31 estudis
- Dallas, TX27 estudis
- Boston, MA26 estudis
- Washington, DC26 estudis
- Los Angeles, CA24 estudis
- Baltimore, MD24 estudis
- St. Louis, MO22 estudis
- Philadelphia, PA21 estudis
- Seattle, WA21 estudis
- Edison, NJ21 estudis
Altres estudis a Orange
- Càncer de pulmó de cèl·lules no petites25 estudis
- Càncer metastàtic20 estudis
- Càncer colorrectal16 estudis
- Càncer d'ovari16 estudis
- Càncer de pàncrees15 estudis
- Càncer de mama14 estudis
- Càncer de pulmó14 estudis
- Càncer de pròstata14 estudis
- Càncer de fetge (carcinoma hepatocel·lular)14 estudis
- Melanoma14 estudis
- Leucèmia mieloide aguda13 estudis
- Càncer (tots els tipus)13 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.